Literature DB >> 19741035

Purification and mechanism of human aldehyde oxidase expressed in Escherichia coli.

Joshua F Alfaro1, Carolyn A Joswig-Jones, Wenyun Ouyang, Joseph Nichols, Gregory J Crouch, Jeffrey P Jones.   

Abstract

Human aldehyde oxidase 1 (AOX1) has been subcloned into a vector suitable for expression in Escherichia coli, and the protein has been expressed. The resulting protein is active, with sulfur being incorporated in the molybdopterin cofactor. Expression levels are modest, but 1 liter of cells supplies enough protein for both biochemical and kinetic characterization. Partial purification is achieved by nickel affinity chromatography through the addition of six histidines to the amino-terminal end of the protein. Kinetic analysis, including kinetic isotope effects and comparison with xanthine oxidase, reveal similar mechanisms, with some subtle differences. This expression system will allow for the interrogation of human aldehyde oxidase structure/function relationships by site-directed mutagenesis and provide protein for characterizing the role of AOX1 in drug metabolism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19741035      PMCID: PMC2784701          DOI: 10.1124/dmd.109.029520

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  37 in total

1.  The combi-targeting concept: synthesis of stable nitrosoureas designed to inhibit the epidermal growth factor receptor (EGFR).

Authors:  Juozas Domarkas; Fabienne Dudouit; Christopher Williams; Qiu Qiyu; Ranjita Banerjee; Fouad Brahimi; Bertrand Jacques Jean-Claude
Journal:  J Med Chem       Date:  2006-06-15       Impact factor: 7.446

Review 2.  Biology of the molybdenum cofactor.

Authors:  Ralf R Mendel
Journal:  J Exp Bot       Date:  2007-03-09       Impact factor: 6.992

3.  Human xanthine oxidase changes its substrate specificity to aldehyde oxidase type upon mutation of amino acid residues in the active site: roles of active site residues in binding and activation of purine substrate.

Authors:  Yuichiro Yamaguchi; Tomohiro Matsumura; Kimiyoshi Ichida; Ken Okamoto; Takeshi Nishino
Journal:  J Biochem       Date:  2007-02-14       Impact factor: 3.387

Review 4.  Drug-metabolizing ability of molybdenum hydroxylases.

Authors:  Shigeyuki Kitamura; Kazumi Sugihara; Shigeru Ohta
Journal:  Drug Metab Pharmacokinet       Date:  2006-04       Impact factor: 3.614

5.  Use of density functional calculations to predict the regioselectivity of drugs and molecules metabolized by aldehyde oxidase.

Authors:  Rhonda A Torres; Kenneth R Korzekwa; Daniel R McMasters; Christine M Fandozzi; Jeffrey P Jones
Journal:  J Med Chem       Date:  2007-08-25       Impact factor: 7.446

6.  Small-interference RNA-mediated knock-down of aldehyde oxidase 1 in 3T3-L1 cells impairs adipogenesis and adiponectin release.

Authors:  Johanna Weigert; Markus Neumeier; Sabrina Bauer; Wolfgang Mages; Andreas A Schnitzbauer; Aiman Obed; Benedikt Gröschl; Arndt Hartmann; Andreas Schäffler; Charalampos Aslanidis; Jürgen Schölmerich; Christa Buechler
Journal:  FEBS Lett       Date:  2008-07-29       Impact factor: 4.124

Review 7.  Mammalian aldehyde oxidases: genetics, evolution and biochemistry.

Authors:  E Garattini; M Fratelli; M Terao
Journal:  Cell Mol Life Sci       Date:  2008-04       Impact factor: 9.261

8.  Electronic structure description of the cis-MoOS unit in models for molybdenum hydroxylases.

Authors:  Christian J Doonan; Nick D Rubie; Katrina Peariso; Hugh H Harris; Sushilla Z Knottenbelt; Graham N George; Charles G Young; Martin L Kirk
Journal:  J Am Chem Soc       Date:  2007-12-07       Impact factor: 15.419

9.  Cloning, expression, and characterization of male cynomolgus monkey liver aldehyde oxidase.

Authors:  Kouichi Hoshino; Kunio Itoh; Akiko Masubuchi; Mayuko Adachi; Tasuku Asakawa; Nobuaki Watanabe; Toshiyuki Kosaka; Yorihisa Tanaka
Journal:  Biol Pharm Bull       Date:  2007-07       Impact factor: 2.233

10.  Role of the molybdoflavoenzyme aldehyde oxidase homolog 2 in the biosynthesis of retinoic acid: generation and characterization of a knockout mouse.

Authors:  Mineko Terao; Mami Kurosaki; Maria Monica Barzago; Maddalena Fratelli; Renzo Bagnati; Antonio Bastone; Chiara Giudice; Eugenio Scanziani; Alessandra Mancuso; Cecilia Tiveron; Enrico Garattini
Journal:  Mol Cell Biol       Date:  2008-11-03       Impact factor: 4.272

View more
  19 in total

1.  Inhibition of human liver aldehyde oxidase: implications for potential drug-drug interactions.

Authors:  John T Barr; Jeffrey P Jones
Journal:  Drug Metab Dispos       Date:  2011-09-22       Impact factor: 3.922

2.  The impact of single nucleotide polymorphisms on human aldehyde oxidase.

Authors:  Tobias Hartmann; Mineko Terao; Enrico Garattini; Christian Teutloff; Joshua F Alfaro; Jeffrey P Jones; Silke Leimkühler
Journal:  Drug Metab Dispos       Date:  2012-01-25       Impact factor: 3.922

3.  Absolute quantification of aldehyde oxidase protein in human liver using liquid chromatography-tandem mass spectrometry.

Authors:  John T Barr; Jeffrey P Jones; Carolyn A Joswig-Jones; Dan A Rock
Journal:  Mol Pharm       Date:  2013-09-19       Impact factor: 4.939

4.  Molybdenum enzymes in higher organisms.

Authors:  Russ Hille; Takeshi Nishino; Florian Bittner
Journal:  Coord Chem Rev       Date:  2011-05-01       Impact factor: 22.315

5.  Interspecies differences in the metabolism of methotrexate: An insight into the active site differences between human and rabbit aldehyde oxidase.

Authors:  Kanika V Choughule; Carolyn A Joswig-Jones; Jeffrey P Jones
Journal:  Biochem Pharmacol       Date:  2015-05-29       Impact factor: 5.858

Review 6.  The mononuclear molybdenum enzymes.

Authors:  Russ Hille; James Hall; Partha Basu
Journal:  Chem Rev       Date:  2014-01-28       Impact factor: 60.622

7.  Correlating C-H bond cleavage with molybdenum reduction in xanthine oxidase.

Authors:  Martin L Kirk; Abebe Berhane
Journal:  Chem Biodivers       Date:  2012-09       Impact factor: 2.408

8.  Why do most human liver cytosol preparations lack xanthine oxidase activity?

Authors:  John T Barr; Kanika V Choughule; Sahadev Nepal; Timothy Wong; Amarjit S Chaudhry; Carolyn A Joswig-Jones; Michael Zientek; Stephen C Strom; Erin G Schuetz; Kenneth E Thummel; Jeffrey P Jones
Journal:  Drug Metab Dispos       Date:  2014-01-15       Impact factor: 3.922

9.  Evaluation of rhesus monkey and guinea pig hepatic cytosol fractions as models for human aldehyde oxidase.

Authors:  Kanika V Choughule; John T Barr; Jeffrey P Jones
Journal:  Drug Metab Dispos       Date:  2013-08-05       Impact factor: 3.922

10.  Site-Directed Mutagenesis at the Molybdenum Pterin Cofactor Site of the Human Aldehyde Oxidase: Interrogating the Kinetic Differences Between Human and Cynomolgus Monkey.

Authors:  Armina Abbasi; Carolyn A Joswig-Jones; Jeffrey P Jones
Journal:  Drug Metab Dispos       Date:  2020-10-05       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.